Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Arix Bioscience (ARIX)

Arix Bioscience Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:ARIX
DateTimeSourceHeadlineSymbolCompany
13/02/202408:00RNS Regulatory NewsLondon Stock Exchange Notice Cancellation - Arix Bioscience plcLSE:ARIXArix Bioscience Plc
12/02/202412:53Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience shares suspended ahead of RTW takeoverLSE:ARIXArix Bioscience Plc
12/02/202412:00EQS Regulatory NewsScheme EffectiveLSE:ARIXArix Bioscience Plc
12/02/202407:00EQS Regulatory NewsSuspension of Trading in SharesLSE:ARIXArix Bioscience Plc
07/02/202411:30EQS Regulatory NewsTransaction UpdateLSE:ARIXArix Bioscience Plc
29/01/202412:15EQS Regulatory NewsResults of First General MeetingLSE:ARIXArix Bioscience Plc
24/01/202417:30EQS Regulatory NewsHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
24/01/202417:30UK RegulatoryHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
24/01/202417:30UK RegulatoryHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
23/01/202407:00EQS Regulatory NewsUpdate on the Scheme and Publication of Notice of Second General MeetingLSE:ARIXArix Bioscience Plc
23/01/202407:00UK RegulatoryUpdate on the Scheme and Publication of Notice of Second General MeetingLSE:ARIXArix Bioscience Plc
22/01/202416:22Alliance NewsAlliance NewsIN BRIEF: RTW Biotech completes Arix investment in takeover run-upLSE:ARIXArix Bioscience Plc
22/01/202407:00EQS Regulatory NewsUpdate on the Scheme and Resignation of DirectorsLSE:ARIXArix Bioscience Plc
22/01/202407:00UK RegulatoryUpdate on the Scheme and Resignation of DirectorsLSE:ARIXArix Bioscience Plc
19/01/202411:29Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience eyes USD19 million return from Harpoon saleLSE:ARIXArix Bioscience Plc
19/01/202407:01EQS Regulatory NewsFinancial update on Harpoon Therapeutics acquisition by Merck (MSD)LSE:ARIXArix Bioscience Plc
19/01/202407:01UK RegulatoryFinancial update on Harpoon Therapeutics acquisition by Merck (MSD)LSE:ARIXArix Bioscience Plc
19/01/202407:00EQS Regulatory NewsUnaudited NAV for December 2023LSE:ARIXArix Bioscience Plc
19/01/202407:00UK RegulatoryUnaudited NAV for December 2023LSE:ARIXArix Bioscience Plc
08/01/202417:15EQS Regulatory NewsPortfolio company Harpoon Therapeutics to be acquired by Merck (MSD)LSE:ARIXArix Bioscience Plc
08/01/202417:15UK RegulatoryPortfolio company Harpoon Therapeutics to be acquired by Merck (MSD)LSE:ARIXArix Bioscience Plc
05/01/202407:00EQS Regulatory NewsPublication of Circular and RTW Bio ProspectusLSE:ARIXArix Bioscience Plc
05/01/202407:00UK RegulatoryPublication of Circular and RTW Bio ProspectusLSE:ARIXArix Bioscience Plc
04/01/202417:30EQS Regulatory NewsHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
04/01/202417:30UK RegulatoryHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
22/12/202311:00UK RegulatoryUpdate regarding timing of Proposed Scheme of ReconstructionLSE:ARIXArix Bioscience Plc
13/12/202307:00UK RegulatoryUnaudited NAV for November 2023LSE:ARIXArix Bioscience Plc
08/12/202307:00UK RegulatoryPortfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass TrialLSE:ARIXArix Bioscience Plc
13/11/202316:00UK RegulatoryCorrection: Portfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockLSE:ARIXArix Bioscience Plc
10/11/202308:00UK RegulatoryPortfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockLSE:ARIXArix Bioscience Plc
 Showing the most relevant articles for your search:LSE:ARIX